Dr. Andrew Dueck obtained his medical degree from Queen’s University in 1999 and then trained in General Surgery at the University of Toronto during which time he also completed a Masters degree in clinical epidemiology. He then went on to complete a Fellowship in Vascular Surgery at the University of Toronto. Following this he did additional training at Arizona Heart Institute in minimally invasive and image-guided cardiovascular surgery.
Dr. Dueck is the head of the division of vascular surgery and co-director of the vascular laboratory at Sunnybrook Health Sciences Centre and an assistant professor in the department of surgery at University of Toronto. He has sat on a variety of regional, provincial, and national committees for the planning and delivery of vascular surgery services including the Executive of the Canadian Society for Vascular Surgery, the Cardiac Care Network, and CorHealth. He is an associate scientist at the Sunnybrook Research Institute and an adjunct scientist at the Li Ka Shing Knolwedge Institute.
Dr. Dueck’s research interests include novel approaches to cardiovascular imaging, the evaluation of novel percutaneous or endovascular devices or therapeutics, and outcomes following cardiovascular interventions. He has done extensive research into peripheral plaque characterization and flow independent MRI Imaging for patients with peripheral arterial disease. This work has generated multiple patents. Dr. Dueck is the co-founder and director of Magellan Biomedical, a medical device company that seeks to enhance navigation during cardiovascular interventions.
iGan Arabia invests in emerging companies with strong IP that can benefit the MENA healthcare systems and populations. With a focus on data-driven medical device and digital health technologies, we invest in dynamic management teams, empowering them to build impactful and highly scalable businesses.
Privacy Policy | © 2024 iGan Partners. All Rights Reserved.